Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Fujiwara

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Obstetrics and Gynaecology Research|November 4, 2020
Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabineYoshifumi Takahashi, Yuji Takei, Shizuo Machida, et al.
Experimental and Therapeutic Medicine|May 27, 2022
Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case reportShuntaro Umihira, Takahiro Koyanagi, Kohei Tamura, et al.
Oncology|August 22, 2003
Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancerShizuo Machida, Michitaka Ohwada, Hiroyuki Fujiwara, et al.
International Journal of Oncology|January 19, 2018
Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7Naoto Sato, Yasushi Saga, Ryosuke Uchibori, et al.
Cancer Science|April 26, 2013
Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3Kayoko Takahashi, Hiroaki Mizukami, Yasushi Saga, et al.
The Journal of Obstetrics and Gynaecology Research|December 10, 2016
Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimensYuji Takei, Yoshifumi Takahashi, Shizuo Machida, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 21, 2019
Perinatal outcome of pregnancy after adenomyomectomy: summary of 10 cases with a brief literature reviewMizuho Sugiyama, Hironori Takahashi, Yosuke Baba, et al.
Oncology|May 24, 2014
Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancerShizuo Machida, Yuji Takei, Chikako Yoshida, et al.
Cancer Reports (Hoboken, N.J.)|April 24, 2025
Progesterone Enhances Sensitivity of Ovarian Cancer Cells to SN38 Through Inhibition of Topoisomerase I and Inducing FerroptosisTakahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 22, 2023
Automated electrochemiluminescence immunoassay for serum PlGF levels in women with singleton pregnancy at 9-13 weeks of gestation predicts preterm preeclampsia: a retrospective cohort studyAkihide Ohkuchi, Kayo Takahashi, Chikako Hirashima, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Obstetrics and Gynaecology Research|November 4, 2020
Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabineYoshifumi Takahashi, Yuji Takei, Shizuo Machida, et al.
Experimental and Therapeutic Medicine|May 27, 2022
Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case reportShuntaro Umihira, Takahiro Koyanagi, Kohei Tamura, et al.
Oncology|August 22, 2003
Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancerShizuo Machida, Michitaka Ohwada, Hiroyuki Fujiwara, et al.
International Journal of Oncology|January 19, 2018
Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7Naoto Sato, Yasushi Saga, Ryosuke Uchibori, et al.
Cancer Science|April 26, 2013
Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3Kayoko Takahashi, Hiroaki Mizukami, Yasushi Saga, et al.
The Journal of Obstetrics and Gynaecology Research|December 10, 2016
Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimensYuji Takei, Yoshifumi Takahashi, Shizuo Machida, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 21, 2019
Perinatal outcome of pregnancy after adenomyomectomy: summary of 10 cases with a brief literature reviewMizuho Sugiyama, Hironori Takahashi, Yosuke Baba, et al.
Oncology|May 24, 2014
Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancerShizuo Machida, Yuji Takei, Chikako Yoshida, et al.
Cancer Reports (Hoboken, N.J.)|April 24, 2025
Progesterone Enhances Sensitivity of Ovarian Cancer Cells to SN38 Through Inhibition of Topoisomerase I and Inducing FerroptosisTakahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 22, 2023
Automated electrochemiluminescence immunoassay for serum PlGF levels in women with singleton pregnancy at 9-13 weeks of gestation predicts preterm preeclampsia: a retrospective cohort studyAkihide Ohkuchi, Kayo Takahashi, Chikako Hirashima, et al.
Pageof 18